Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2014
08/07/2014US20140221463 Methods for heart regeneration
08/07/2014US20140221462 Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxia
08/07/2014US20140221461 Nucleic acid molecules and uses thereof
08/07/2014US20140221459 Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells
08/07/2014US20140221457 Ameliorating oxidative stress in neurodegenerative disease via nox1 targeting
08/07/2014US20140221455 Differentiation modulating agents and uses therefor
08/07/2014US20140221453 D-serine transporter inhibitors as pharmaceutical compositions for the treatment of visual system disorders
08/07/2014US20140221452 Compositions comprising eicosapentaenoic acid and 5-htp and methods of use thereof
08/07/2014US20140221451 Implants for the treatment of dopamine associated states
08/07/2014US20140221449 Dividable galenical form allowing modified release of the active ingredient
08/07/2014US20140221447 Formulation for preventing or reducing bleeding at a surgical site
08/07/2014US20140221446 Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance
08/07/2014US20140221445 Aqueous ophthalmic solutions of phentolamine and medical uses thereof
08/07/2014US20140221442 Use of dianhydrogalactitol and analogs and derivatives thereof to treat glioblastoma multiforme
08/07/2014US20140221439 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
08/07/2014US20140221436 Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease
08/07/2014US20140221434 Altering pharmacokinetics of pirfenidone therapy
08/07/2014US20140221430 Solid Forms of 3-(6-(1-(2,2-Difluorobenzo[D][1,3]Dioxol-5-yl)Cyclopropanecarboxamido)-3-Methylpyridin-2-yl)Benzoic Acid
08/07/2014US20140221429 Heterocyclic schiff's bases as novel and new antiglycation agents
08/07/2014US20140221428 Arylsulfonamide ccr3 antagonists
08/07/2014US20140221426 Selective metabolic approach to increasing oral bioavailability of phenylephrine and other phenolic bioactivities
08/07/2014US20140221424 Pharmaceutical compositions for use in the treatment of cystic fibrosis
08/07/2014US20140221421 Therapeutic compounds
08/07/2014US20140221418 Hyaluronic acid based copolymers
08/07/2014US20140221416 Tamper Resistant Pharmaceutical Formulations
08/07/2014US20140221415 Method of Treating Dyskinesia
08/07/2014US20140221414 Solid dispersion of rifaximin
08/07/2014US20140221413 Preoperative treatment of post operative pain
08/07/2014US20140221407 Use and application of a pharmaceutical composition containing a mixture of natural-origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies
08/07/2014US20140221405 Platelet adp receptor inhibitors
08/07/2014US20140221404 FUSION GENE OF Kif5b GENE AND Ret GENE, AND METHOD FOR DETERMINING EFFECTIVENESS OF CANCER TREATMENT TARGETING FUSION GENE
08/07/2014US20140221400 Use of myeloperoxidase (mpo) inhibitors or pharmaceutically acceptable salts thereof to treat multiple sysyem atrophy (msa) 938
08/07/2014US20140221399 Method of treating functional somatic syndromes with combination of famciclovir and celecoxib
08/07/2014US20140221396 Tubulin inhibitors
08/07/2014US20140221395 Deuterium-Enriched Alkyl Sulfonamides and Uses Thereof
08/07/2014US20140221389 Use of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one in the treatment of cancer in moderate hepatic impaired patients
08/07/2014US20140221388 Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
08/07/2014US20140221386 Combinations of akt inhibitor compounds and erlotinib, and methods of use
08/07/2014US20140221385 Combinations of serotonin receptor agonists for treatment of movement disorders
08/07/2014US20140221383 Cetp inhibitors
08/07/2014US20140221381 Thienopyrimidine compounds and use thereof
08/07/2014US20140221380 SUBSTITUTED SPIROPYRIDO[1,2-a]PYRAZINE DERIVATIVE AND PHARMACEUTICAL USE OF SAME AS HIV INTEGRASE INHIBITOR
08/07/2014US20140221372 Method of administration and treatment
08/07/2014US20140221370 Pyrrolopyridines as kinase inhibitors
08/07/2014US20140221368 Biomarkers of therapeutic responsiveness
08/07/2014US20140221366 Substituted Azaheterocycles for the Treatment of Cancer
08/07/2014US20140221365 Alkylated piperazine compounds
08/07/2014US20140221364 Tetrahydroquinoline analogues as muscarinic agonists
08/07/2014US20140221361 C-19 modified triterpenoids with hiv maturation inhibitory activity
08/07/2014US20140221358 Compositions comprising eicosapentaenoic acid and diazoxide and methods of use thereof
08/07/2014US20140221356 Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
08/07/2014US20140221354 IMIDAZO [1,2-a]PYRIDINE COMPOUNDS FOR USE IN THERAPY
08/07/2014US20140221352 Compositions and methods for inhibition of the jak pathway
08/07/2014US20140221349 Indanyloxydihydrobenzofuranylacetic acids
08/07/2014US20140221347 Therapeutic compounds
08/07/2014US20140221346 Therapeutic compounds
08/07/2014US20140221341 Bicyclic compounds and their use as antibacterial agents and betalactamase inhibitors
08/07/2014US20140221333 Btk inhibitors
08/07/2014US20140221331 Regulation of nitric oxide release and biofilm development
08/07/2014US20140221330 Ndm inhibitor
08/07/2014US20140221329 Novel estrogen receptor mutations and uses thereof
08/07/2014US20140221327 Method of Diagnosing and Therapeutically Treating a Patient for a Traumatic Brain Injury
08/07/2014US20140221326 Ophthalmologic irrigation solutions and method
08/07/2014US20140221324 Composition for the reduction of drip losses in pork
08/07/2014US20140221322 Heteroaryl substituted urea modulators of fatty acid amide hydrolase
08/07/2014US20140221321 Compositions and Methods for the Treatment of Neurodegenerative and Other Diseases
08/07/2014US20140221320 Topical minocycline ointment for suppression of allergic skin responses
08/07/2014US20140221319 Small Molecule CD38 Inhibitors and Methods of Using Same
08/07/2014US20140221309 Eye drop formulation with enhanced properties by combining sodium hyaluronate with carboxymethylcellulose
08/07/2014US20140221307 In-situ gel forming compositions
08/07/2014US20140221306 Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate
08/07/2014US20140221305 Compositions and Methods for Treating Cancer
08/07/2014US20140221304 5'-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseases
08/07/2014US20140221302 Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (vap) and ventilator associated tracheal (vat) bronchitis
08/07/2014US20140221301 Combination treatment for cancer
08/07/2014US20140221297 Topical antiviral formulations
08/07/2014US20140221294 Sulphated hyaluronic acid for treating degenerative osteoarthritis
08/07/2014US20140221286 Sodium channel blockers reduce glucagon secretion
08/07/2014US20140220676 Method and Medicament for Inhibiting the Expression of a Given Gene
08/07/2014US20140220612 Fluorinated resorufin compounds and their application
08/07/2014US20140220600 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines
08/07/2014US20140220590 Methods of using benzothiazole derivative compounds and compositions
08/07/2014US20140220165 Compositions for the treatment of peripheral ulcers of various origins
08/07/2014US20140220162 Preparation comprising amino acids and plants and its activity in the alcohol detoxification
08/07/2014US20140220157 Method of debriding tissue
08/07/2014US20140220156 Method of promoting mucosal reciliation
08/07/2014US20140220155 Vaginal tissue rejuvenation compositions and methods
08/07/2014US20140220154 Method of treating pathologic heterotopic ossification
08/07/2014US20140220152 Compositions and Methods for Detecting, Treating, or Preventing Reductive Stress
08/07/2014US20140220151 Stability in Vitamin and Mineral Supplements
08/07/2014US20140220149 Method for prevention and treatment of reflux injury in the aerodigestive tract and laryngopharynx caused by pepsin
08/07/2014US20140220146 Use of opioid antagonists for treating urinary retention
08/07/2014US20140220144 Orally disintegrating tablet compositions of lamotrigine
08/07/2014US20140220141 Compositions of lopinavir and ritonavir
08/07/2014US20140220140 Compositions of efavirenz
08/07/2014US20140220139 Skin composition for external use containing ceramides
08/07/2014US20140220132 Pharmaceutical Formulation Comprising Compounds of the Jasmonate Family
08/07/2014US20140220129 Compositions Comprising S-Adenosylmethionine and a Gallic Acid Ester
08/07/2014US20140220128 Solid Dosage Form
08/07/2014US20140220127 Reduction of opioid blood fluctuations
1 ... 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 ... 7860